News
News

The latest updates from AFAR.

Board Members in the News: Nir Barzilai and S. Jay Olshansky on positive impact  of older  2020 presidential candidates in NBC News THINK

Oct 17
2019

Board Members in the News: Nir Barzilai and S. Jay Olshansky on positive impact of older 2020 presidential candidates in NBC News THINK

On October 11, 2019, NBC News THINK published an opinion piece co-authored by AFAR experts Nir Barzilai, MD, and S. Jay Olshanksy, PhD, on why health matter more than age when considering a presidential candidate, citing the research-backed AFAR whitepaper by Dr. Olshansky. The experts argue that older candidates reflect a positive societal shift as more Americans are living healthier for longer. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner,…


View MoreREAD MORE


Board Members in the News: Nir Barzilai and S. Jay Olshansky on the longevity and healthspan of the 2020 candidates in Mother Jones

Oct 11
2019

Board Members in the News: Nir Barzilai and S. Jay Olshansky on the longevity and healthspan of the 2020 candidates in Mother Jones

On October 8, 2019, Mother Jones featured insights from AFAR experts Nir Barzilai, MD, and S. Jay Olshansky, PhD, on why health matters more than age when considering a presidential candidate, referencing the research-backed AFAR whitepaper by Dr. Olshansky. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, and the  Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine. Dr. Olshansky is…


View MoreREAD MORE


AFAR in the news: AFAR selected as National Program Office for new NIA Clin-STAR Coordinating Center

Oct 7
2019

AFAR in the news: AFAR selected as National Program Office for new NIA Clin-STAR Coordinating Center

  AFAR is pleased to announce that the National Institute on Aging (NIA), part of the National Institutes of Health (NIH, will be awarding nearly $4.5 million over the next five years in support of a new Clin-STAR (Clinician-Scientists Transdisciplinary Aging Research) Coordinating Center. AFAR will serve as the Coordinating Center’s National Program Office; additionally, three Academic Resource Centers at Yale University School of Medicine; University of California, San Francisco; Johns Hopkins University comprise the Coordinating Center. The Clin-STAR Coordinating Center will develop a multi-faceted, national platform to promote and enrich the career development, training and trans-disciplinary research of…


View MoreREAD MORE


Board Member in the news: Mark Lachs on healthspan and longevity of presidential candidates in The New York Times

Oct 7
2019

Board Member in the news: Mark Lachs on healthspan and longevity of presidential candidates in The New York Times

On October 2, 2019, The New York Times featured insights from AFAR expert Mark S. Lachs, MD, MPH, on why age should not be a disqualifying factor for the presidency, and why healthspan matters more than age. Dr. Lachs is the AFAR board President, a 1995 Paul B. Beeson Emerging Leaders Career Development Award in Aging recipient, and a 2017 Irving S. Wright Award winner. He is also the Director of Geriatrics for The New York Presbyterian Health Care System, as well as the Co-Chief of Geriatrics and Palliative Medicine and the Irene and Roy Psaty Distinguished Professor of Medicine at the Weill Cornell…


View MoreREAD MORE


Grantees in the News: Jorge Ivan Castillo-Quan and Linda Partridge on triple drug combo and longevity of fruit flies PNAS

Oct 7
2019

Grantees in the News: Jorge Ivan Castillo-Quan and Linda Partridge on triple drug combo and longevity of fruit flies PNAS

On September 30, 2019, Proceedings of the National Academy of Sciences of the United States of America (PNAS) published research by AFAR experts Jorge Ivan Castillo-Quan, PhD, and  Linda Partridge, DPhil, which found that a triple drug combination, including Rapamycin, extended the lifespan of fruit flies by 48 percent. Dr. Castillo-Quan is a 2018 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research recipient, and a Research Fellow in Medicine at Harvard Catalyst. Dr. Partridge is a 2010 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient. She is also the Managing Director of the Max Planck Institute for Biology…


View MoreREAD MORE




BACK TO TOPBACK TO TOP